4425 Anibiotic-Resistant Organism Acquisition in Nursing Facility Patients. Issue Volume 4:Issue(2020)Supplement 1 (June 2020)
- Record Type:
- Journal Article
- Title:
- 4425 Anibiotic-Resistant Organism Acquisition in Nursing Facility Patients. Issue Volume 4:Issue(2020)Supplement 1 (June 2020)
- Main Title:
- 4425 Anibiotic-Resistant Organism Acquisition in Nursing Facility Patients
- Authors:
- Wang, Joyce
Cassone, Marco
Gibson, Kristen
Lansing, Bonnie
Mody, Lona
Snitkin, Evan
Rao, Krishna - Abstract:
- Abstract : OBJECTIVES/GOALS: We investigated the association between gut microbiota features in newly admitted nursing facility (NF) patients and the acquisition of vancomycin-resistant Enterococcus (VRE) and/or resistant Gram-negative bacteria (rGNB) within 14 days. METHODS/STUDY POPULATION: Patients were recruited at 6 Michigan NFs from 09/16-08/18. VRE or rGNB colonization status was determined by culture swabs collected from multiple body sites at enrolment, day 7, and day 14. Our analysis focused on patients with no colonization at baseline, a perirectal swab collected at baseline, and at least one follow-up visit. The V4 hypervariable region of the 16S rRNA gene from bacterial DNA in each sample was PCR-amplified and sequenced on the MiSeq platform. Sequencing results were then processed with the mothur bioinformatics pipeline to classify bacterial taxa present in each sample. Taxa typically associated with the skin microbiota were removed. The primary outcome was acquisition of VRE and/or rGNB within 14 days. Exposures of interest included patient and microbiota characteristics. RESULTS/ANTICIPATED RESULTS: Among 61 patients, 18 (30%) acquired AROs within 14 days of enrolment (3 VRE, 13 rGNB, 2 both) (Table 1 ). The baseline microbiota features differed significantly in those who acquired a new ARO. Of the major 8 phyla found across samples, patients who acquired an ARO were depleted in the number of phyla present (5.74 ± 1.20 vs 5.06 ± 1.43; p = 0.037) (Fig. 1 ). TheAbstract : OBJECTIVES/GOALS: We investigated the association between gut microbiota features in newly admitted nursing facility (NF) patients and the acquisition of vancomycin-resistant Enterococcus (VRE) and/or resistant Gram-negative bacteria (rGNB) within 14 days. METHODS/STUDY POPULATION: Patients were recruited at 6 Michigan NFs from 09/16-08/18. VRE or rGNB colonization status was determined by culture swabs collected from multiple body sites at enrolment, day 7, and day 14. Our analysis focused on patients with no colonization at baseline, a perirectal swab collected at baseline, and at least one follow-up visit. The V4 hypervariable region of the 16S rRNA gene from bacterial DNA in each sample was PCR-amplified and sequenced on the MiSeq platform. Sequencing results were then processed with the mothur bioinformatics pipeline to classify bacterial taxa present in each sample. Taxa typically associated with the skin microbiota were removed. The primary outcome was acquisition of VRE and/or rGNB within 14 days. Exposures of interest included patient and microbiota characteristics. RESULTS/ANTICIPATED RESULTS: Among 61 patients, 18 (30%) acquired AROs within 14 days of enrolment (3 VRE, 13 rGNB, 2 both) (Table 1 ). The baseline microbiota features differed significantly in those who acquired a new ARO. Of the major 8 phyla found across samples, patients who acquired an ARO were depleted in the number of phyla present (5.74 ± 1.20 vs 5.06 ± 1.43; p = 0.037) (Fig. 1 ). The log10-transformed relative abundance of Enterococcus was enriched in patients who acquired an ARO (−0.32 ± 1.47) compared to those who did not (−1.68 ± 1.76; p = 0.021) (Fig. 2 ). Patients who did not acquire an ARO tended to harbour more butyrate-producing bacterial taxa and strict anaerobes, although the differences were not statistically significant (relative abundance of butyrate producer: 29.49 ± 22.09 vs 22.05 ± 17.76; anaerobes: 64.78 ± 23.54 vs 53.68 ± 27.61). DISCUSSION/SIGNIFICANCE OF IMPACT: Microbiota metrics calculated from perirectal samples are predictive of ARO acquisition. The clinical utility of perirectal samples thus warrants further assessment. … (more)
- Is Part Of:
- Journal of clinical and translational science. Volume 4:Issue(2020)Supplement 1
- Journal:
- Journal of clinical and translational science
- Issue:
- Volume 4:Issue(2020)Supplement 1
- Issue Display:
- Volume 4, Issue 1 (2020)
- Year:
- 2020
- Volume:
- 4
- Issue:
- 1
- Issue Sort Value:
- 2020-0004-0001-0000
- Page Start:
- 2
- Page End:
- 3
- Publication Date:
- 2020-06
- Subjects:
- Clinical medicine -- Research -- Periodicals
Medicine, Experimental -- Periodicals
Human experimentation in medicine -- Periodicals
616.027 - Journal URLs:
- https://www.cambridge.org/core/journals/journal-of-clinical-and-translational-science ↗
- DOI:
- 10.1017/cts.2020.54 ↗
- Languages:
- English
- ISSNs:
- 2059-8661
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library HMNTS - ELD Digital store
- Ingest File:
- 14683.xml